Master of Science in Pharmaceutical Economics and Policy (MS)

School of Pharmacy

Location: Boston, Online
Start Term: Fall, Spring

Prepare to assume a role in pharmaceutical and healthcare economics or policy with the knowledge and expertise you build in this strategic program.

Unlock Multiple Career Options in Analysis-Based Decision Making

This strategic STEM-designated program focuses on pharmaceutical economics and policy, global drug policy, pharmacoeconomics, outcomes research, health epidemiology, and pharmacoepidemiology. Designed to fit your life, it gives you the choice to study in-person at our Boston campus or online and to begin your studies in the fall or spring semester. The Boston-based program offers both a thesis (separate application needed) and a non-thesis option. The online program is an asynchronous non-thesis course of study and is intended primarily for part-time students.

Your Learning Experience

The program is designed to be completed in two years, whether you study at the Boston campus or online. This program is STEM-designated, allowing students on an F-1 visa who attend the on-campus delivery of the curriculum (in person), to qualify for an additional two years of Optional Practical Training (OPT), for a total of three years of OPT in the United States.

First-Year Experience

  • learn about health epidemiology, health economics, outcomes research, and comparative pharmaceutical healthcare systems
  • study statistics and regression analysis
  • begin participation in a graduate seminar in pharmaceutical economics and policy

Second-Year Experience

  • explore the application of meta-analysis, pharmacoepidemiology, health services research, health care decision analysis and patient reported outcomes
  • explore market access pricing, reimbursement, and pharmacoeconomic applications
  • complete a capstone in data analysis and presentation capabilities or an MS thesis

Online program

The requirements for the online program are identical to those for the in-person program except in the following areas:

  • Enroll in just two courses per term if you need to fit the program around a heavy work and family schedule.
  • Take courses during the summer term so you will be able to complete the program in two calendar years.
  • An additional three-credit elective serves as a substitute for the three credits given for the thesis or the seminar requirement in the non-thesis option.

*Domestic students and international students not residing in the U.S. are eligible for the online program.

Pharmaceutical Economics and Policy at MCPHS

Mitchell Lobo_horizontal.jpg
Focused student wearing glasses, looking at laptop screen, listening to a lecture.

MS in Pharmaceutical Economics and Policy (PEP) - Online

Tailored to suit your lifestyle this online program is structured asynchronously, catering especially to those balancing their studies with other commitments.
Focused student wearing glasses, looking at laptop screen, listening to a lecture.

Other MCPHS Programs in Regulatory Affairs and PEP

We offer these additional opportunities for graduate study at the master’s, doctoral, and certificate levels for students interested in drug development and regulation as well as pharmaceutical economics and policy.

Master of Science in Regulatory Affairs and Health Policy

Choose full- or part-time study or whether to start in the fall, spring, or summer semester. The program takes place both on the MCPHS Boston campus and online.

Graduate Certificate in Regulatory Affairs

Start in the fall, spring, or summer semester. The program takes place both on the MCPHS Boston campus and online.

Graduate Certificate in Health Policy

Start in the fall, spring, or summer semester. The program takes place both on the MCPHS Boston campus and online.

Doctor of Philosophy in Pharmaceutical Economics and Policy

Start in the fall or spring. The program takes place on the MCPHS Boston campus.

Download a Program Fact Sheet

Download a program fact sheet for a snapshot of the Master of Science in Pharmaceutical Economics and Policy.